Edgewise Therapeutics, Inc.

NASDAQ (USD): Edgewise Therapeutics, Inc. (EWTX)

Last Price

29.66

Today's Change

+0.04 (0.13%)

Day's Change

28.68 - 29.92

Trading Volume

401,870

Overview

Market Cap

2 Billion

Shares Outstanding

94 Million

Avg Volume

872,217

Avg Price (50 Days)

32.72

Avg Price (200 Days)

22.59

PE Ratio

-19.77

EPS

-1.50

Earnings Announcement

20-Feb-2025

Previous Close

29.62

Open

29.46

Day's Range

28.68 - 29.92

Year Range

9.0 - 38.12

Trading Volume

428,997

Price Change Highlight

1 Day Change

0.14%

5 Day Change

-2.88%

1 Month Change

-7.54%

3 Month Change

14.12%

6 Month Change

69.68%

Ytd Change

169.64%

1 Year Change

211.55%

3 Year Change

105.83%

5 Year Change

-1.13%

10 Year Change

-1.13%

Max Change

-1.13%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment